VertiGIS Continues to Grow with the Acquisition of SynerGIS GIS & FM Solutions
VertiGIS announced today the completed acquisition of SynerGIS GIS & FM Solutions GmbH, based in Innsbruck, Austria. SynerGIS GIS & FM Solutions develops geographic information system (GIS) software for a variety of market segments, including local and regional governments, utilities, exploration and industry. SynerGIS GIS & FM Solutions will officially join VertiGIS’s AED-SICAD business unit after more than a decade of existing commercial partnership via their shared subsidiary, AED-SYNERGIS. SynerGIS & FM Solutions and AED-SYNERGIS are now part of VertiGIS’s DACH solutions group, which is comprised of AED-SICAD, Geocom and Dynamic Design.
The SynerGIS solutions GeoOffice, WebOffice and ProOffice are used by thousands of customers daily. The products leverage the market-leading ArcGIS® platform from Esri and are therefore highly compatible with all current IT infrastructure. The fast and effective integration of SynerGIS applications within existing corporate processes contributes enormously to information and planning security, as well as helping drive the development of geospatial intelligence within customers’ organizations.
SynerGIS’s CEO Peter Remesch explains: “We look forward to the collaboration and new opportunities that arise as part of VertiGIS for our products and solutions. For our customers, this means securing their investments in the long term and partnering with the leading Esri partner in the DACH region.”
“For VertiGIS this is the next logical step in the implementation of our growth strategy. The acquisition of SynerGIS GIS & FM Solutions helps us expand our market reach and optimize our common development, sales and marketing efforts. The fit with SynerGIS GIS & FM Solutions is perfect, as our approach to the market, our technology base, and our corporate culture is highly similar,” says Dr. Holger Schade, CEO of AED-SICAD.
The extended VertiGIS will serve more than 12,000 users worldwide. Its primary product brands include UT for ArcGIS, LM for ArcGIS, Geocortex, GEONIS, ConnectMaster, GeoOffice, WebOffice, and ProOffice.
VertiGIS is a leading solution provider and software developer in the area of geographic information systems. Its focus is the development of software solutions and services for the market segments utilities and land management, governments, and industry. The product portfolio is used by more than 10,000 users in private sector companies and government agencies. In addition to its North American footprint with Geocortex, VertiGIS maintains a strong presence in the DACH region via its business units AED-SICAD, Dynamic Design Group, SynerGIS GIS & FM Solutions, and Geocom. Further information at www.vertigis.com.
About Battery Ventures:
Battery strives to invest in cutting-edge, category-defining businesses in markets including software and services, Web infrastructure, consumer Internet, mobile and industrial technologies. Founded in 1983, the firm backs companies at stages ranging from seed to private equity and invests globally from offices in Boston, the San Francisco Bay Area, London, Israel and New York. Follow the firm on Twitter @BatteryVentures, visit our website at www.battery.com and find a full list of Battery's portfolio companies here.
About SynerGIS GIS & FM Solutions:
SynerGIS GIS & FM Solutions owns the products GeoOffice, WebOffice and ProOffice and is a spin-off of SynerGIS Informationssysteme GmbH, the official Esri distributor for Austria and Slovakia. SynerGIS GIS & FM Solutions includes the former SynerGIS CAD-Info-Systeme founded in 1989 in Innsbruck, the WebOffice development in Vienna and 50% of the shares in AED-SYNERGIS GmbH in Bonn. The GeoOffice, WebOffice and ProOffice products are used by more than 2,000 users, primarily in the DACH region. Further information at www.mysynergis.com.
Dr. Holger Schade, CEO - AED-SICAD GmbH
Address: Carl-Wery Strasse 22, 81739 München, Germany
Phone: +49 (89) 45026 0
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ResMed Inc. Completes $500M Private Placement Debt Offering15.7.2019 20:05:00 CEST | Press release
ResMed Inc. (NYSE: RMD, ASX: RMD) announced today the successful pricing and closing of a private placement offering of $250,000,000 principal amount 3.24% senior notes due July 10, 2026, and $250,000,000 principal amount 3.45% senior notes due July 10, 2029. Net proceeds from the offering will be approximately $498 million, after deducting estimated fees and expenses related to the offering. The net proceeds will be used to pay down current borrowings on ResMed’s senior unsecured revolving credit facility. The notes are senior unsecured obligations of ResMed, and jointly and severally guaranteed by each Subsidiary Guarantor. “We are pleased to complete this U.S. private placement offering on attractive terms,” said Brett Sandercock, ResMed’s chief financial officer. “The transaction significantly lengthens our average debt maturity profile and provides improved visibility on our long-term funding costs.” This private placement offering is exempt from the registration requirements of t
SpeeDx Receives Clearance from Health Canada for ResistancePlus® MG Test15.7.2019 15:00:00 CEST | Press release
SpeeDx Pty. Ltd. today announced Resistance Plus® MG has been cleared by Health Canada and is now available for sale across all Canadian provinces (not currently available in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen, along with genetic markers linked to antibiotic resistance. This is the first commercially available test in Canada combining identification and therapeutic guidance information to support Resistance Guided Therapy for management of Mgen. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005544/en/ (Photo: Business Wire) Current Canadian management guidelines for Mgen direct laboratories to forward positive samples to the National Microbiology Laboratory for resistance testing.1 Now Canadian laboratories can utilize Resistance Plus MG and bring this service inhouse to generate more timely results for doctors and their p
Mouser Electronics Now Stocking Broad Portfolio of Xilinx Products15.7.2019 14:55:00 CEST | Press release
Mouser Electronics, Inc. today announces a new global distribution agreement with Xilinx, Inc., the leader in adaptive and intelligent computing, to stock one of the industry’s broadest portfolios of Xilinx products, including digital downloads of development software and IP. Xilinx is the inventor of the FPGA, hardware programmable system-on-chips (SoCs) and the adaptive compute acceleration platform (ACAP), designed to deliver the most dynamic processor technology in the industry and enable the adaptable, intelligent and connected world of the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005546/en/ Mouser Electronics proudly announces a new global distribution agreement with Xilinx, Inc., the leader in adaptive and intelligent computing. Mouser will stock one of the industry’s broadest portfolios of Xilinx products. (Graphic: Business Wire) To learn more, visit www.mouser.com/xilinx. “Xilinx is an industry
Rimini Street Becomes Support Service Provider for Hyundai-Kia Motors’ Global Database Portfolio15.7.2019 13:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that it has been selected as the software support services provider to global auto manufacturer Hyundai-Kia Motors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005161/en/ Rimini Street announced that it has been selected as the software support services provider to global auto manufacturer Hyundai-Kia Motors. (Photo: Business Wire) By providing efficient, timely, and cost-effective database maintenance and support, Rimini Street plans to actively support Hyundai-Kia Motors in their endeavor to implement a business-driven IT roadmap. Cost Optimization and Desire for Quality Support To support response to paradigm shifts in the automobile industry and active technology innovation, Hyundai-Kia Motors se
Värde Partners Appoints Co-CEO15.7.2019 12:12:00 CEST | Press release
Värde Partners, a leading global alternative investment firm, today announced that Ilfryn Carstairs will join George Hicks, Co-Founder and Chief Executive Officer, as Co-CEO, effective January 1, 2020. George co-founded Värde Partners 25 years ago and intends to transition to an Executive Chair role in 2022. Ilfryn will retain his role as Global CIO. “Transition is a process and involves the entirety of the firm. The roles Ilfryn and I play are just part of that process whereby a new generation of leaders succeed the founders,” said George. “Ilfryn joined us 12 years into this journey and has grown as both an investor and a leader. His skills in both pursuits will enable Värde to continue delivering for our investors and will help to ensure that we maintain our strong culture long into the future.” Ilfryn is a Partner and Co-Chief Investment Officer overseeing the global investment strategy for Värde. He co-chairs the firm’s Investment Committee. Based in Singapore since 2017, he joine
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform15.7.2019 12:00:00 CEST | Press release
Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeutic cancer vaccines derived from its technology platform KISIMA. AMAL’s lead vaccine ATP128 is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month. Boehringer Ingelheim plans to develop new therapies by combining assets from its cancer immunology portfolio with AMAL’s proprietary KISIMA immunization platform. “Acquiring AMAL is part of Boehringer Ingelheim’s long-term strategy to enhance our existing position as an innovator of novel cancer therapies, including immuno-oncology treatments, which leverage cutting-edge scientific discoveries and their applications,” said Michel Pairet, member of Boehringer Ingelheim’s Board of Managing Directors with responsibility for the company’s Innovation Unit. “We want to pioneer new paradigms